Table 2 Stenting as bail-out treatment of vasospasm after aSAH: loading medication, stent dimensions, target vessel, vessel segment, Nimodipine IV after stenting, thrombus formation, bleeding complication
Patient number | Group | Loading medication | Stent dimensions | Target vessel | Vessel segments (diameters in mm) | Nimodipine IV after stenting (days) | Thrombus after stenting | Peri- or postprocedural bleeding |
|---|---|---|---|---|---|---|---|---|
1 | 1 | 1 × 500 mg ASA 1 × 75 mg PRA | Solitaire 4/15 | ACA rt | A1-A2 (0.7–0.5 mm) | Yes (14 days) | no | no |
2 | 1 | 1 × 4 mg EPT 2 × 500 mg ASA 1 × 600 mg CLO | LVIS Jr 2.5/24 | MCA rt | ICA-M1-M2 (1–0.7–0.4 mm) | Yes (7 days) | Transient Thrombus formation resolved: EPT IA | no |
3 | 2 | 1 × 500 mg ASA 1 × 30 mg PRA | Enterprise 4/39 | MCA rt | M1-M2 (0.4–0.5 mm) | Yes (9 days) | no | no |
4 | 2 | 1 × 12.4 mg EPT 1 × 500 mg ASA 1 × 180 mg TIC | Enterprise2 4/30 | MCA rt | M1-M2 (0.3–0.7 mm) | Yes (19 days) | no | no |
5 | 2 | 1 × 500 mg ASA 1 × 10 mg PRA | Enterprise2 4/16 1 × Enterprise2 4/23 | MCA rt ACA rt | M1 (0.7 mm) A1-A2 (0.6–0.7 mm) | Yes (11 days) | no | no |
6 | 2 | 1 × 12.4 mg EPT 1 × 500 mg ASA 1 × 180 mg TIC | Neuroform Atlas 3/15 Baby Leo 2/12 Neuroform Atlas 4/24 Neuroform Atlas 4.5/30 | ACA rt ACA rt MCA lt ICA lt | A2 (0.5 mm) A1 (0.6 mm) ICA-M1 (1.7–0.6 mm) A1-A2 (0.5–0.4 mm) | Yes (8 days) | no | no |